Adenovirus Vector: Gaining Popularity for Oncology Gene Therapy

2024-04-20 09:58:08 Industry

858

?Citing the potential of gene therapy in treating life-threatening diseases, companies are engaged in developing appropriate vectors for producing effective gene therapy?, says RNCOS.

According to RNCOS? new research report ?Global Gene Therapy Market Forecast to 2020?, a major focus has been on the ongoing clinical trials for the development of innovative products using different vectors.

One of the majorly used vectors was adenoviral vector. Adenoviral vectors consist of several features that make them well suited for this application. They are highly effective in gene therapy due to their ability to efficiently transduce in both dividing as well as non-dividing cells.

Adenoviral vector is the most used vector in oncology application. This vector system has shown real promise in treating cancer and indeed the first gene therapy product (Gendicine) to be licensed is an adenovirus to treat cancer. According to the Journal of Gene Medicine, July 2015, 506 trials have been reported using adenoviral vector. Currently, adenoviral vectors are being used in suicide gene therapy, gene-based immunotherapy, gene replacement strategies, and in approaches that combine gene therapy with chemotherapy. In addition, treatment with replication competent adenovirus vectors is also showing promising results in clinical trials

Research Analysis and Highlights
The report is spread in over 190 pages and provides an in-depth research and rational analysis of the global gene therapy market. An effective analysis of the key therapeutic areas has been included in the report followed by the analysis of different clinical trials phase and different vector utilized in the key therapeutic areas. A brief overview of the key geographies in the gene therapy segment and the regulatory scenario governing the industry has also been included in the study to present a balanced outlook. The report covers how major trends and drivers, including nanotechnology, advanced therapies to treat chronic diseases etc., will propel the industry?s growth. With a view to understand the competitive landscape, the profiles of key market players are included in the report to present a complete picture of the global gene therapy market.

Some of the key highlights of the report include the following:
? Mergers and Acquisitions advancing gene therapy research and development
? US showing dynamic research and development for gene therapy.
? Growing clinical trials for gene therapy worldwide.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM804.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.